Ready-Willing-Able: Early childhood mortality decline in Turkey.

Ready–Willing–Able framework cultural bottlenecks delaying mortality transitions cultural resistance and mortality decline early childhood mortality lags in mortality underachievers in mortality

Journal

Population studies
ISSN: 1477-4747
Titre abrégé: Popul Stud (Camb)
Pays: England
ID NLM: 0376427

Informations de publication

Date de publication:
07 2022
Historique:
pubmed: 4 5 2022
medline: 8 7 2022
entrez: 3 5 2022
Statut: ppublish

Résumé

We test a conjecture to explain Turkey's decades-long 'underachievement' in early child mortality improvements. We argue that it is largely a consequence of cultural barriers to embracing available modern medical technology and healthcare practices. The empirical test rests on a reformulation of Coale's Ready-Willing-Able (RWA) framework for explaining fertility changes, which makes it suitable to understand mortality changes. We use structural equation modelling and Demographic and Health Surveys spanning 1993-2013 to estimate basic parameters of the reformulated framework. These parameters are then used to classify mothers into four groups with different configurations of RWA dimensions and different probabilities of adopting modern medical practices. We find that observed behaviours in these groups were consistent with RWA expectations. In addition, we find that an important contributor to Turkey's lagging mortality decline was a population distribution biased towards groups more reticent to adopting modern healthcare.

Identifiants

pubmed: 35502930
doi: 10.1080/00324728.2022.2058596
pmc: PMC9256781
mid: NIHMS1792367
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

273-293

Subventions

Organisme : NIA NIH HHS
ID : R01 AG018016
Pays : United States
Organisme : NIDA NIH HHS
ID : R03 DA015673
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG016209
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG052030
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW001586
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG017266
Pays : United States
Organisme : NIA NIH HHS
ID : R37 AG025216
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG056608
Pays : United States
Organisme : NICHD NIH HHS
ID : R24 HD047873
Pays : United States

Références

Soc Sci Med. 2001 Jan;52(1):53-69
pubmed: 11144917
Popul Stud (Camb). 1975 Jul;29:231-48
pubmed: 11630494
Health Transit Rev. 1992 Oct;2(2):131-49
pubmed: 10148654
Soc Sci Med. 1989;28(6):571-6
pubmed: 2648604
Popul Stud (Camb). 1987;41(2):207-35
pubmed: 11621337

Auteurs

Rengin Aktar (R)

Istanbul Bilgi University.

Alberto Palloni (A)

University of Wisconsin-Madison.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH